Allergan, Inc. (AGN) · page 108 of 110
This slide attempts to normalize earnings by removing costs the company deems non-recurring.
Activist deck · preempt_rebuttal · preempt_rebuttal · sparse density
Slide locked Sign in to view
Slide schematic 3/3
callout 1/1 list 1/1 title 1/1
Components 3
primary bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.